What Is Hindsight Bias In Investing?
You’ve probably heard the expression “hindsight is 20/20.” That saying…
Buy
64
IHI Quote, Financials, Valuation and Earnings
Last price:
$59.92
Seasonality move
:
5.38%
Day range:
$59.89 - $61.08
52-week range:
$53.72 - $65.18
Dividend yield:
0.45%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
1.6M
Avg. volume:
828.7K
1-year change:
5.83%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IHI
iShares US Medical Devices ETF
|
-- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | -- | -- | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | -- | -- | -- | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IHI
iShares US Medical Devices ETF
|
$60.29 | -- | -- | -- | $0.03 | 0.45% | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
$168.18 | -- | -- | -- | $1.17 | 0.7% | -- |
|
IBB
iShares Biotechnology ETF
|
$132.97 | -- | -- | -- | $0.12 | 0.29% | -- |
|
IXJ
iShares Global Healthcare ETF
|
$91.29 | -- | -- | -- | $0.62 | 1.41% | -- |
|
IYH
iShares US Healthcare ETF
|
$60.83 | -- | -- | -- | $0.16 | 1.19% | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
$22.19 | -- | -- | -- | $0.22 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IHI
iShares US Medical Devices ETF
|
-- | 1.267 | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | 1.243 | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | 1.306 | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | 1.049 | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | 1.117 | -- | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
-- | 0.000 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IHI
iShares US Medical Devices ETF
|
-- | -- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
-- | -- | -- | -- | -- | -- |
iShares US Medical Devices ETF vs. Competitors
-
Which has Higher Returns IHI or FBT?
First Trust NYSE Arca Biotechnology Index Fund has a net margin of -- compared to iShares US Medical Devices ETF's net margin of --. iShares US Medical Devices ETF's return on equity of -- beat First Trust NYSE Arca Biotechnology Index Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHIiShares US Medical Devices ETF-- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- -
What do Analysts Say About IHI or FBT?
iShares US Medical Devices ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust NYSE Arca Biotechnology Index Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Medical Devices ETF has higher upside potential than First Trust NYSE Arca Biotechnology Index Fund, analysts believe iShares US Medical Devices ETF is more attractive than First Trust NYSE Arca Biotechnology Index Fund.
Company Buy Ratings Hold Ratings Sell Ratings IHIiShares US Medical Devices ETF0 0 0 FBTFirst Trust NYSE Arca Biotechnology Index Fund0 0 0 -
Is IHI or FBT More Risky?
iShares US Medical Devices ETF has a beta of 0.914, which suggesting that the stock is 8.632% less volatile than S&P 500. In comparison First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.732, suggesting its less volatile than the S&P 500 by 26.822%.
-
Which is a Better Dividend Stock IHI or FBT?
iShares US Medical Devices ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.45%. First Trust NYSE Arca Biotechnology Index Fund offers a yield of 0.7% to investors and pays a quarterly dividend of $1.17 per share. iShares US Medical Devices ETF pays -- of its earnings as a dividend. First Trust NYSE Arca Biotechnology Index Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHI or FBT?
iShares US Medical Devices ETF quarterly revenues are --, which are smaller than First Trust NYSE Arca Biotechnology Index Fund quarterly revenues of --. iShares US Medical Devices ETF's net income of -- is lower than First Trust NYSE Arca Biotechnology Index Fund's net income of --. Notably, iShares US Medical Devices ETF's price-to-earnings ratio is -- while First Trust NYSE Arca Biotechnology Index Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Medical Devices ETF is -- versus -- for First Trust NYSE Arca Biotechnology Index Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHIiShares US Medical Devices ETF-- -- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- --
-
Which has Higher Returns IHI or IBB?
iShares Biotechnology ETF has a net margin of -- compared to iShares US Medical Devices ETF's net margin of --. iShares US Medical Devices ETF's return on equity of -- beat iShares Biotechnology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHIiShares US Medical Devices ETF-- -- -- IBBiShares Biotechnology ETF-- -- -- -
What do Analysts Say About IHI or IBB?
iShares US Medical Devices ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Medical Devices ETF has higher upside potential than iShares Biotechnology ETF, analysts believe iShares US Medical Devices ETF is more attractive than iShares Biotechnology ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHIiShares US Medical Devices ETF0 0 0 IBBiShares Biotechnology ETF0 0 0 -
Is IHI or IBB More Risky?
iShares US Medical Devices ETF has a beta of 0.914, which suggesting that the stock is 8.632% less volatile than S&P 500. In comparison iShares Biotechnology ETF has a beta of 0.794, suggesting its less volatile than the S&P 500 by 20.628%.
-
Which is a Better Dividend Stock IHI or IBB?
iShares US Medical Devices ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.45%. iShares Biotechnology ETF offers a yield of 0.29% to investors and pays a quarterly dividend of $0.12 per share. iShares US Medical Devices ETF pays -- of its earnings as a dividend. iShares Biotechnology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHI or IBB?
iShares US Medical Devices ETF quarterly revenues are --, which are smaller than iShares Biotechnology ETF quarterly revenues of --. iShares US Medical Devices ETF's net income of -- is lower than iShares Biotechnology ETF's net income of --. Notably, iShares US Medical Devices ETF's price-to-earnings ratio is -- while iShares Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Medical Devices ETF is -- versus -- for iShares Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHIiShares US Medical Devices ETF-- -- -- -- IBBiShares Biotechnology ETF-- -- -- --
-
Which has Higher Returns IHI or IXJ?
iShares Global Healthcare ETF has a net margin of -- compared to iShares US Medical Devices ETF's net margin of --. iShares US Medical Devices ETF's return on equity of -- beat iShares Global Healthcare ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHIiShares US Medical Devices ETF-- -- -- IXJiShares Global Healthcare ETF-- -- -- -
What do Analysts Say About IHI or IXJ?
iShares US Medical Devices ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Global Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Medical Devices ETF has higher upside potential than iShares Global Healthcare ETF, analysts believe iShares US Medical Devices ETF is more attractive than iShares Global Healthcare ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHIiShares US Medical Devices ETF0 0 0 IXJiShares Global Healthcare ETF0 0 0 -
Is IHI or IXJ More Risky?
iShares US Medical Devices ETF has a beta of 0.914, which suggesting that the stock is 8.632% less volatile than S&P 500. In comparison iShares Global Healthcare ETF has a beta of 0.675, suggesting its less volatile than the S&P 500 by 32.526%.
-
Which is a Better Dividend Stock IHI or IXJ?
iShares US Medical Devices ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.45%. iShares Global Healthcare ETF offers a yield of 1.41% to investors and pays a quarterly dividend of $0.62 per share. iShares US Medical Devices ETF pays -- of its earnings as a dividend. iShares Global Healthcare ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHI or IXJ?
iShares US Medical Devices ETF quarterly revenues are --, which are smaller than iShares Global Healthcare ETF quarterly revenues of --. iShares US Medical Devices ETF's net income of -- is lower than iShares Global Healthcare ETF's net income of --. Notably, iShares US Medical Devices ETF's price-to-earnings ratio is -- while iShares Global Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Medical Devices ETF is -- versus -- for iShares Global Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHIiShares US Medical Devices ETF-- -- -- -- IXJiShares Global Healthcare ETF-- -- -- --
-
Which has Higher Returns IHI or IYH?
iShares US Healthcare ETF has a net margin of -- compared to iShares US Medical Devices ETF's net margin of --. iShares US Medical Devices ETF's return on equity of -- beat iShares US Healthcare ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHIiShares US Medical Devices ETF-- -- -- IYHiShares US Healthcare ETF-- -- -- -
What do Analysts Say About IHI or IYH?
iShares US Medical Devices ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Medical Devices ETF has higher upside potential than iShares US Healthcare ETF, analysts believe iShares US Medical Devices ETF is more attractive than iShares US Healthcare ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHIiShares US Medical Devices ETF0 0 0 IYHiShares US Healthcare ETF0 0 0 -
Is IHI or IYH More Risky?
iShares US Medical Devices ETF has a beta of 0.914, which suggesting that the stock is 8.632% less volatile than S&P 500. In comparison iShares US Healthcare ETF has a beta of 0.692, suggesting its less volatile than the S&P 500 by 30.803%.
-
Which is a Better Dividend Stock IHI or IYH?
iShares US Medical Devices ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.45%. iShares US Healthcare ETF offers a yield of 1.19% to investors and pays a quarterly dividend of $0.16 per share. iShares US Medical Devices ETF pays -- of its earnings as a dividend. iShares US Healthcare ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHI or IYH?
iShares US Medical Devices ETF quarterly revenues are --, which are smaller than iShares US Healthcare ETF quarterly revenues of --. iShares US Medical Devices ETF's net income of -- is lower than iShares US Healthcare ETF's net income of --. Notably, iShares US Medical Devices ETF's price-to-earnings ratio is -- while iShares US Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Medical Devices ETF is -- versus -- for iShares US Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHIiShares US Medical Devices ETF-- -- -- -- IYHiShares US Healthcare ETF-- -- -- --
-
Which has Higher Returns IHI or THNR?
Amplify Weight Loss Drug & Treatment ETF has a net margin of -- compared to iShares US Medical Devices ETF's net margin of --. iShares US Medical Devices ETF's return on equity of -- beat Amplify Weight Loss Drug & Treatment ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHIiShares US Medical Devices ETF-- -- -- THNRAmplify Weight Loss Drug & Treatment ETF-- -- -- -
What do Analysts Say About IHI or THNR?
iShares US Medical Devices ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Amplify Weight Loss Drug & Treatment ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Medical Devices ETF has higher upside potential than Amplify Weight Loss Drug & Treatment ETF, analysts believe iShares US Medical Devices ETF is more attractive than Amplify Weight Loss Drug & Treatment ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHIiShares US Medical Devices ETF0 0 0 THNRAmplify Weight Loss Drug & Treatment ETF0 0 0 -
Is IHI or THNR More Risky?
iShares US Medical Devices ETF has a beta of 0.914, which suggesting that the stock is 8.632% less volatile than S&P 500. In comparison Amplify Weight Loss Drug & Treatment ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock IHI or THNR?
iShares US Medical Devices ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.45%. Amplify Weight Loss Drug & Treatment ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.22 per share. iShares US Medical Devices ETF pays -- of its earnings as a dividend. Amplify Weight Loss Drug & Treatment ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHI or THNR?
iShares US Medical Devices ETF quarterly revenues are --, which are smaller than Amplify Weight Loss Drug & Treatment ETF quarterly revenues of --. iShares US Medical Devices ETF's net income of -- is lower than Amplify Weight Loss Drug & Treatment ETF's net income of --. Notably, iShares US Medical Devices ETF's price-to-earnings ratio is -- while Amplify Weight Loss Drug & Treatment ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Medical Devices ETF is -- versus -- for Amplify Weight Loss Drug & Treatment ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHIiShares US Medical Devices ETF-- -- -- -- THNRAmplify Weight Loss Drug & Treatment ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Rivian a Good Stock a Buy?
Rivian Automotive (RIVN) had an initial IPO of close to…
Will Chevron Acquire Hess?
Long-time Buffett favorite in the energy sector Chevron (NYSE:CVX) is…
Stock Ideas
Buy
58
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
29
UNF alert for Mar 26
UniFirst [UNF] is up 1.54% over the past day.
Sell
30
KEQU alert for Mar 26
Kewaunee Scientific [KEQU] is down 3.3% over the past day.
Buy
82
EPAC alert for Mar 26
Enerpac Tool Group [EPAC] is down 2.32% over the past day.
